Similar companies
| Company | Business Outlook | |
|---|---|---|
 |
AmgenAMGN |
66% 0% |
 |
Gilead SciencesGILD |
57% 1.8% |
 |
Catalyst PharmaceuticalsCPRX |
75% 0% |
 |
Inovio PharmaceuticalsINO |
27% 0% |
 |
Anavex Life SciencesAVXL |
0% 0% |
What Do Tarsus Pharmaceuticals Employees Think About the Company?
81% of Tarsus Pharmaceuticals (TARS) employees currently report a positive business outlook, based on anonymous employee surveys aggregated by AltIndex. This is a strong reading, which suggests employees are confident in the direction of the company.
The score is roughly flat (+0.0%) over the past three months.
At 81% positive, Tarsus Pharmaceuticals’s employee business outlook ranks ahead of industry peers like Amgen (66%) and Gilead Sciences (57%).
Why Employee Sentiment Matters for TARS Stock
Employee business outlook can be a leading indicator: the people inside the business see operational changes, leadership decisions, and market shifts before they reach an earnings report. AltIndex feeds Tarsus Pharmaceuticals’s outlook score into the TARS AI Score as one of 25+ alternative data signals, weighed alongside hiring, web traffic, and fundamentals.
For other employment signals, see Tarsus Pharmaceuticals’s job postings, LinkedIn headcount, and overall employee rating.
Month over Month
| Sep 2026 | 81% | |
| Aug 2026 | 81% | |
| Jul 2026 | 81% | |
| Jun 2026 | 81% | |
| May 2026 | 89% | |
| Apr 2026 | 100% |
Tarsus Pharmaceuticals Employee Business Outlook: Frequently Asked Questions
81% of Tarsus Pharmaceuticals employees report a positive business outlook. This is based on anonymous employee surveys aggregated by AltIndex and updated regularly.
A 81% reading is strong — a clear majority of Tarsus Pharmaceuticals employees are positive about where the business is headed.
No single signal predicts a stock on its own, but employee business outlook can be a leading indicator: employees see operational changes, morale shifts, and strategic pivots before they appear in quarterly earnings. AltIndex combines it with 25+ other signals in the TARS AI Score rather than reading any one signal in isolation.
Tarsus Pharmaceuticals overperforms a majority of its industry peers when it comes to Business Outlook, ranking in the 81st percentile.
There has been no meaningful change in the business outlook amongst employees at Tarsus Pharmaceuticals.
Sign up and get more insights on the business outlook at Tarsus Pharmaceuticals.
See Tarsus Pharmaceuticals’s complete business outlook history
Sign up to unlock 1-year and all-time charts for TARS, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREE
